Ian Gourley

639 total citations
36 papers, 390 citations indexed

About

Ian Gourley is a scholar working on Immunology, Rheumatology and Hematology. According to data from OpenAlex, Ian Gourley has authored 36 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Rheumatology and 5 papers in Hematology. Recurrent topics in Ian Gourley's work include Systemic Lupus Erythematosus Research (5 papers), T-cell and B-cell Immunology (5 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Ian Gourley is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), T-cell and B-cell Immunology (5 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Ian Gourley collaborates with scholars based in United States, France and United Kingdom. Ian Gourley's co-authors include Joan Korth‐Bradley, A. L. Bell, Deeksha Bali, Kyle Matschke, Michael F. Seldin, Christopher I. Amos, Virginia Parks, Lawrence Fleckenstein, Malek Kamoun and Stephan Chalon and has published in prestigious journals such as The Journal of Immunology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ian Gourley

30 papers receiving 375 citations

Peers

Countries citing papers authored by Ian Gourley

Since Specialization

Citations

This map shows the geographic impact of Ian Gourley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Gourley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Gourley more than expected).

Fields of papers citing papers by Ian Gourley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Gourley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Gourley. The network helps show where Ian Gourley may publish in the future.

Co-authorship network of co-authors of Ian Gourley

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Gourley. A scholar is included among the top collaborators of Ian Gourley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Gourley. Ian Gourley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis 2024 ·Toxicological Sciences ·Marc Pallardy, Rami Bechara, Jessica Whritenour, (unknown), Danuta J. Herzyk, Hervé Lebrec, Hans F. Merk, Ian Gourley, Wendy Komocsar, Joseph R. Piccotti, Mercedesz Balázs, Amy Sharma, (unknown), Daniel Weinstock	7
2	Careers Guidance and Inspiration in Schools 2017 ·Ian Gourley	1
3	Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus 2016 ·Clinical Therapeutics ·Stanley Cohen, Megan E. B. Clowse, P. Gómez Pardo, (unknown), Sandeep Menon, Ian Gourley, (unknown)	3
4	First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28 2016 ·The Journal of Immunology ·Nicolas Poirier, Gilles Blancho, (unknown), Caroline Mary, Tim Van Assche, (unknown), Steven Ramael, Weirong Wang, Virginie Thépenier, Cécile Braudeau, Nina Salabert, Régis Josien, I.E. Anderson, Ian Gourley, Jean‐Paul Soulillou, (unknown), Bernard Vanhove	47
5	Safety and Efficacy of SBI-087, a Subcutaneous Agent for B Cell Depletion, in Patients with Active Rheumatoid Arthritis: Results from a Phase II Randomized, Double-blind, Placebo-controlled Study 2016 ·The Journal of Rheumatology ·Nemanja Damjanov, Małgorzata Tłustochowicz, Jacob Aelion, Maria Greenwald, (unknown), (unknown), Elena Peeva, Sandeep Menon, Ian Gourley	4
6	Local Government Transparency 2016 ·Ian Gourley	1
7	Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures 2013 ·The Journal of Clinical Pharmacology ·Indranil Bhattacharya, Mark H. Gotfried, Allena Ji, (unknown), Ian Gourley, (unknown), Joan Korth‐Bradley	13
8	Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects 2013 ·Clinical Pharmacology in Drug Development ·Joan Korth‐Bradley, Virginia Parks, Frank Wagner, Stephan Chalon, Ian Gourley, Kyle Matschke, (unknown), Sharon L. Ripp, Lawrence Fleckenstein	15
9	Comparative Sirolimus Pharmacokinetics After Single‐Dose Administration of Two Prototype 0.5‐mg Tablets in Healthy Volunteers 2012 ·Clinical Pharmacology in Drug Development ·Joan Korth‐Bradley, Indranil Bhattacharya, Kyle Matschke, (unknown), (unknown), Ian Gourley	1
10	Excretion of Moxidectin into Breast Milk and Pharmacokinetics in Healthy Lactating Women 2011 ·Antimicrobial Agents and Chemotherapy ·Joan Korth‐Bradley, Virginia Parks, Stephan Chalon, Ian Gourley, Kyle Matschke, (unknown), Philip Bryson, Lawrence Fleckenstein	36
11	Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs 2009 ·Journal of Immunotoxicology ·Joseph R. Piccotti, Hervé Lebrec, Ellen W. Evans, Danuta J. Herzyk, Kenneth L. Hastings, Leigh Ann Burns‐Naas, Ian Gourley, Daniel Wierda, Thomas T. Kawabata	6
12	Optimization of analytical and pre-analytical variables associated with an ex vivo cytokine secretion assay 2005 ·Journal of Pharmaceutical and Biomedical Analysis ·Chad Ray, Carmen M. Dumaual, (unknown), (unknown), Peter J. O’Brien, Ian Gourley, Viswanath Devanarayan, Robert J. Konrad	13
13	The effect of recipient cytokine gene polymorphism on cardiac transplantation outcome 2004 ·Human Immunology ·Ian Gourley, David DeNofrio, William Rand, Shashank Desai, Evan Loh, Malek Kamoun	12
14	Profound Bias in Interferon‐γ and Interleukin‐6 Allele Frequencies in Western Kenya, Where Severe Malarial Anemia Is Common in Children 2002 ·The Journal of Infectious Diseases ·Ian Gourley, Jonathan D. Kurtis, Malek Kamoun, Joseph J Amon, (unknown)	18
15	HLA Class I typing of volunteers for a bone marrow registry: QC analysis by DNA‐based methodology identifies serological typing discrepancies in the assignment of HLA‐A and B antigens 2002 ·Tissue Antigens ·Ian Gourley, (unknown), (unknown), (unknown), Maria Brown, Malek Kamoun	13
16	Novel HLA‐B15 alleles identified in potential marrow donors 2000 ·Tissue Antigens* ·Thomas Williams, Jin Wu, (unknown), George D. Montoya, Jie Yin Yee, Barbara Griffith, (unknown), (unknown), (unknown), Ian Gourley, Malek Kamoun	3
17	A novel HLA‐B40 allele and novel exon 1 sequences of two B40 alleles identified in potential marrow donors 2000 ·Tissue Antigens ·Ian Gourley, Jin Wu, (unknown), George D. Montoya, Jie Yin Yee, Barbara Griffith, (unknown), (unknown), (unknown), Thomas M. Williams, Malek Kamoun	6
18	Familial antiphospholipid antibody syndrome: Criteria for disease and evidence for autosomal dominant inheritance 1999 ·Arthritis & Rheumatism ·Niti Goel, Thomas L. Ortel, Deeksha Bali, Joshua P. Anderson, Ian Gourley, Howard R. Smith, Colleen A. Morris, (unknown), D. Ware Branch, P M Ford, (unknown), Robert Roubey, Donna D. Kostyu, Stephen F. Kingsmore, (unknown), Christopher I. Amos, Michael F. Seldin	46
19	Clinical features associated with a positive anticardiolipin antibody in Irish patients with systemic lupus lrythematosus 1996 ·Clinical Rheumatology ·Ian Gourley, S A McMillan, A. L. Bell	9
20	Kikuchi's disease as a presenting feature of mixed connective tissue disease 1995 ·Clinical Rheumatology ·Ian Gourley, A. L. Bell, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact